Login / Signup

Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas.

Mirela-Diana IlieAlexandre VasiljevicPhilippe BertolinoGerald Raverot
Published in: Endocrine reviews (2022)
Pituitary adenomas are neoplasms derived from the endocrine cells of the anterior pituitary gland. Most frequently, they are benign tumors, but may sometimes display an aggressive course, and in some cases metastasize. Their biology, including their wide range of behavior, is only partly understood. In terms of therapeutic targeting, most pituitary adenomas are easily treated with the available medical treatments, surgery, and sometimes radiotherapy. Nevertheless, gonadotroph adenomas lack medical therapeutic options, and treatment of aggressive pituitary adenomas and pituitary carcinomas remains challenging. Here, we present an overview of the implications of tumor microenvironment in pituitary adenomas, reviewing its composition and function, as well as published cases that have been treated thus far using tumor microenvironment-targeting therapies. Additionally, we discuss emerging views, such as the concept of non-angiogenic tumors, and present perspectives regarding treatments that may represent future potential therapeutic options. Tumor-infiltrating lymphocytes, tumor-associated macrophages, folliculostellate cells, tumor-associated fibroblasts, angiogenesis, as well as the extracellular matrix and its remodelling, all have complex roles in the biology of pituitary adenomas. They have been linked to hormone production/secretion, size, invasion, proliferation, progression/recurrence, and treatment response in pituitary adenomas. From a therapeutic perspective, immune-checkpoint inhibitors and bevacizumab have already shown a degree of efficacy in aggressive pituitary adenomas and pituitary carcinomas, and the use of numerous other tumor microenvironment-targeting therapies can be foreseen. In conclusion, similar to other cancers, understanding the tumor microenvironment improves our understanding of pituitary adenoma biology beyond genetics and epigenetics, and constitutes an important tool for developing future therapies.
Keyphrases